Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Lilly (China)
h-index: 44
Total citations: 9,441
Total papers: 474
Homepage:
http://www.lillychina.com/
Recent papers from Lilly (China)
Imlunestrant as Monotherapy or in Combination with Abemaciclib in ER+, HER2− Advanced Breast Cancer: Chinese Subgroup Analysis of the Phase III Randomized EMBER-3 Study
Targeted Oncology · 2026
Association between early body weight reduction and treatment outcomes in participants with obstructive sleep apnoea and obesity: a post hoc analysis of SURMOUNT-OSA trials
EClinicalMedicine · 2026
Evaluation of transplacental clearance prediction methods in maternal-fetal PBPK modeling: Implications for predicting fetal drug exposure
European Journal of Pharmaceutical Sciences · 2026
Breaking Permeation Barriers of Charged Molecules with Excess Permeation Enhancers
The Journal of Physical Chemistry B · 2026
Clinical Characteristics, Treatment Patterns, and Outcomes of Chinese Patients With Alopecia Areata: A Retrospective Observational Study
Journal of Cosmetic Dermatology · 2026
Mirikizumab as Induction and Maintenance Therapy in Chinese Patients with Ulcerative Colitis: A Subpopulation Analysis of the Randomized, Global Phase 3 LUCENT-1 and LUCENT-2 Trials
BioDrugs · 2026
Abstract 7186: Characterization of LY4257496, a novel GRPR antagonist radiolabeled with lutetium-177
Cancer Research · 2026
A Retrospective Observational Study of Safety and Effectiveness of Abemaciclib in Chinese Patients with Breast Cancer
Advances in Therapy · 2026
A comprehensive analysis of pirtobrutinib in Chinese patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma ( CLL / SLL ): Results from the phase 3 study BRUIN CLL ‐321
British Journal of Haematology · 2026
Efficacy of Ixekizumab in Chinese Patients with Radiographic-Axial Spondyloarthritis by Baseline Inflammation Status on Magnetic Resonance Imaging
Rheumatology and Therapy · 2026
Real‐World Long‐Term Effectiveness of Ixekizumab in Chinese Patients With Moderate‐to‐Severe Psoriasis: A Retrospective Data Analysis
Dermatologic Therapy · 2026
Deoxygenative C( sp ³ )–N( sp ³ ) Cross-Coupling Enabled by Nickel Metallaphotoredox Catalysis
Journal of the American Chemical Society · 2025
Safety, Tolerability, and Pharmacokinetics of Galcanezumab, an Anti-CGRP Antibody, in Healthy Chinese Participants.
2025
Long‐term efficacy and safety of tirzepatide in participants with type 2 diabetes with inadequate glycaemic control on metformin and/or sulfonylurea: Post‐hoc analysis of SURPASS ‐4
Diabetes Obesity and Metabolism · 2025
Practical guidance on publishing plain-language summaries for scientific manuscripts with an Asia-Pacific audience
BMC Research Notes · 2025
Development of a Quantitative Method for Formulation Microenvironmental pH Assessment
Molecular Pharmaceutics · 2025
Clinical and Humanistic Burden of Adult Obesity in Asia–Pacific: A Systematic Literature Review
Advances in Therapy · 2025
Current status, perceptions, and barriers regarding weight loss approaches in China
Endocrine · 2025
Advancing liver cancer treatment with dual-targeting CAR-T therapy
Journal of Nanobiotechnology · 2025
Association of tirzepatide with cardiometabolic benefits in Chinese adults: post hoc subgroup analysis of SURMOUNT ‐ CN study
Obesity · 2025